What I think ahz really needs is some breathing space. no one wants to invest in something that is living hand to mouth. Take the current situation as an example. I could invest but I suspect there will be a cr soon which will dilute my holdings and see a discount to the institutional investor, followed by a sp slump. No thanks.
If, however AHZ could raise enough to last for more than a single quarter the risk is reduced significantly. People will be able to invest in the longer term story.
However given the lack of institutional support I suspect our two current investors would rather eek out the findunding, each time gaining more of the company for less.
I reckon a $40m CR with an infusion sale on top would do wonders, throw in a management reshuffle and away it would go! Of course it's probably Not in the best interest of those calling the shots for any of that to happen.
- Forums
- ASX - By Stock
- AVR
- News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-130
-
- There are more pages in this discussion • 438 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.30 |
Change
0.000(0.00%) |
Mkt cap ! $323.4M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 86 | $15.03 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.51 | 897 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 86 | 15.030 |
2 | 112 | 15.020 |
1 | 15 | 15.010 |
2 | 582 | 15.000 |
1 | 1000 | 14.850 |
Price($) | Vol. | No. |
---|---|---|
15.510 | 897 | 2 |
15.520 | 25 | 1 |
15.570 | 779 | 1 |
15.930 | 250 | 1 |
15.940 | 554 | 1 |
Last trade - 10.00am 20/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
Day chart unavailable